<DOC>
	<DOCNO>NCT00090324</DOCNO>
	<brief_summary>The purpose study demonstrate efficacy safety quetiapine fumarate ( SEROQUEL ) compare placebo treatment adolescent patient schizophrenia .</brief_summary>
	<brief_title>Quetiapine Fumarate ( SEROQUEL ) Compared Placebo Treatment Adolescent Patients With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Patient able provide write assent parent legal guardian patient able provide write informed consent begin study related procedure Patient document clinical diagnosis schizophrenia Patient 's parent legal guardian able accompany patient schedule study visit Patients ( female ) must pregnant lactating Patients know intolerance lack response previous treatment quetiapine Patients previously participate study</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Schizophrenia</keyword>
</DOC>